Advertisement
U.S. Markets open in 6 hrs 2 mins

Willow Biosciences Inc. (CANSF)

OTC Markets OTCQB - OTC Markets OTCQB Delayed Price. Currency in USD
0.07000.0000 (0.00%)
At close: 04:00PM EDT
Full screen
Trade prices are not sourced from all markets
Previous Close0.0739
Open0.0739
Bid0.0628 x 0
Ask0.0732 x 0
Day's Range0.0739 - 0.0739
52 Week Range0.0500 - 0.1050
Volume20,000
Avg. Volume37,482
Market Cap10.094M
Beta (5Y Monthly)1.13
PE Ratio (TTM)N/A
EPS (TTM)-0.0400
Earnings DateNov 12, 2024 - Nov 18, 2024
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est2.00
  • PR Newswire

    WILLOW ANNOUNCES A SECOND PROGRAM WITH GLOBAL INGREDIENT MANUFACTURER TO DEVELOP AN ENZYME FOR MANUFACTURING A LARGE VOLUME ACTIVE PHARMACEUTICAL INGREDIENT

    Willow Biosciences Inc. ("Willow") (TSX: WLLW) (OTCQB: CANSF), a leading biotechnology company focused on revolutionizing industrial manufacturing of pure, consistent, and sustainable ingredients, today announced a second program with a leading Active Pharmaceutical Ingredient ("API") manufacturer, to develop a more sustainable, cost-effective manufacturing route for a large volume ingredient used in a therapeutic with a global market in excess of $1 billion. This marks the second development co

  • PR Newswire

    WILLOW ANNOUNCES COMMERCIAL LICENSE AND ROYALTY AGREEMENT WITH KALSEC INC.

    Willow Biosciences Inc. ("Willow") (TSX: WLLW) (OTCQB: CANSF), a leading biotechnology company focused on revolutionizing industrial manufacturing of pure, consistent, and sustainable ingredients, announces signing a commercial license and royalty agreement with Kalsec, Inc. ("Kalsec"), a leading global producer of natural taste and sensory, food protection, colors and advanced hops ingredients for the food and beverage industry. The agreement defines the financial terms for use of Willow's tech